연골 수복 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of cartilage repair Market

The global cartilage repair market size was valued at USD 1.58 billion in 2025 and is projected to reach USD 1.71 billion in 2026 and USD 3.32 billion by 2034, exhibiting a CAGR of 8.7% during the forecast period. North America dominated the global market in 2025 with a 44.93% share. Cartilage repair therapies are designed to restore, regenerate, or replace damaged articular cartilage while preserving surrounding bone structures. These treatments are increasingly used for sports injuries, osteoarthritis, and traumatic cartilage defects. Rising geriatric populations, increasing sports-related injuries, and advancements in regenerative medicine are supporting market growth.

Latest Trends

The increasing adoption of cell- and scaffold-based regenerative cartilage repair is a major market trend. Autologous chondrocyte implantation, matrix-induced cartilage repair, 3D scaffolds, hydrogel-based solutions, and osteochondral allografts are gaining attention among orthopedic and sports medicine providers. Advancements in biologics and 3D printing are also supporting the development of personalized cartilage regeneration solutions.

Market Dynamics

DRIVER - Rising Degenerative Joint Disorders and Sports Injuries:

The increasing prevalence of osteoarthritis, cartilage degradation, and sports-related injuries is driving demand for restorative treatments. Growing geriatric populations and the need to preserve joint function are encouraging patients and clinicians to consider cartilage repair before total joint replacement.

RESTRAINT - High Treatment Costs and Limited Reimbursement:

Advanced cell-based implants, biologics, scaffolds, surgery, cell processing, imaging, and rehabilitation can increase treatment costs. Limited reimbursement in several markets may restrict adoption.

MARKET OPPORTUNITY - Growing Use of Biologics:

Increasing use of platelet-rich plasma, mesenchymal stem cells, and other regenerative approaches for early-stage cartilage damage is creating opportunities for manufacturers and healthcare providers.

CHALLENGE - Long-Term Durability Uncertainty:

Limited long-term evidence regarding the durability of regenerated cartilage remains a challenge. Variations in regenerated tissue quality can also influence treatment selection, particularly among younger and highly active patients.

Segmentation Analysis

By Treatment:

The market is segmented into cell-based approaches and non-cell-based approaches. Non-cell-based approaches held the leading position in 2025 because of their affordability, availability, and comparatively simpler procedures. The cell-based approaches segment is expected to grow at a CAGR of 9.5% during the forecast period.

By Material:

The market includes collagen-based materials, hyaluronic acid-based materials, hydrogel, and others. Collagen-based materials led the market in 2025 and accounted for a 28.9% share in 2026 due to their ability to mimic the natural extracellular matrix. The hydrogel segment is projected to grow at a CAGR of 9.6%.

By Application:

Applications include knee, hip, ankle & foot, shoulder, and other cartilage repair. Knee cartilage repair dominated in 2025 and is expected to account for a 73.9% share in 2026, supported by the high prevalence of knee injuries. Hip cartilage repair is projected to grow at a CAGR of 10.6%.

By End User:

Hospitals & orthopedic clinics dominated in 2025 because of their skilled professionals, advanced imaging equipment, and surgical infrastructure. Academic & research institutes are projected to grow at a CAGR of 8.7%.

Regional Outlook

North America led the market, reaching USD 0.71 billion in 2025, supported by sports injuries and regenerative medicine advancements. The U.S. market is projected to reach USD 0.73 billion in 2026.

Europe is projected to reach USD 0.41 billion in 2026, supported by R&D and product launches. The U.K., Germany, and France are expected to reach USD 0.07 billion, USD 0.09 billion, and USD 0.07 billion, respectively.

Asia Pacific is expected to demonstrate rapid growth and reach USD 0.73 billion in 2026, with China and India estimated at USD 0.12 billion and USD 0.08 billion, respectively. Latin America is projected to reach USD 0.09 billion, while GCC is expected to reach USD 0.02 billion in 2026.

Competitive Landscape

The market has a semi-concentrated structure, with leading companies focusing on product development, regenerative technologies, partnerships, and geographic expansion. Key players include Vericel Corporation, Zimmer Biomet Holdings, Inc., Stryker Corporation, Arthrex, Inc., Smith & Nephew plc, Johnson & Johnson, Anika Therapeutics, Inc., Geistlich Pharma AG, MTF Biologics, and AlloSource.

Investment Analysis & Opportunities

Investment opportunities are emerging across cell therapies, biomaterials, hydrogels, biologics, and advanced scaffold technologies. Companies are increasing R&D spending to develop less invasive and more effective cartilage regeneration solutions. Expanding orthopedic healthcare infrastructure in Asia Pacific also provides opportunities for market participants.

New Product Development

Product development is increasingly focused on advanced scaffolds, biologic materials, cell-based therapies, and regenerative implants. In August 2024, Vericel Corporation introduced MACI Arthro in the U.S., supporting the expansion of advanced cartilage repair solutions.

Five Recent Developments

• November 2025: Anika Therapeutics announced the filing of Hyalofast Cartilage Repair Scaffold for the final phase of its PMA application.
• August 2024: Vericel Corporation introduced MACI Arthro in the U.S.
• May 2024: Altach Biomedical raised USD 1.39 million through Series funding for cartilage injury treatments.
• February 2024: Smith & Nephew showcased cartilage-based sports medicine products at AAOS 2024.
• March 2022: CO.DON AG and JOINT OPERATIONS LLP signed a strategic agreement to distribute Spherox in the U.K.

Report Coverage

The Cartilage Repair Market Report provides detailed analysis of market size, market value, segmentation, regional performance, market trends, market dynamics, competitive landscape, technological advancements, new product development, and key industry developments. It also examines strategic initiatives undertaken by leading companies, including partnerships, funding, product launches, and expansion activities.

Conclusion

The global cartilage repair market is expanding as demand increases for regenerative and joint-preserving treatment options. The market is supported by the rising burden of sports injuries and degenerative joint disorders, while innovations in cell therapies, scaffolds, hydrogels, and biologics are creating new growth opportunities. With the market projected to increase from USD 1.58 billion in 2025 to USD 1.71 billion in 2026 and USD 3.32 billion by 2034, continued technological development and wider adoption of regenerative orthopedic solutions are expected to shape the market outlook.

Attribute Details

Segmentation By Treatment, Material, Application, End User, and Region

By Treatment

• Cell-based Approaches
  • Autologous Chondrocyte Implantation (ACI)
  • Stem Cell-based Therapy
  • Others
• Non-cell-based Approaches
  • Osteochondral Allograft Transplantation
  • Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
  • Others

By Material

• Collagen-based Materials
• Hyaluronic Acid-based Materials
• Hydrogel
• Others

By Application

• Knee Cartilage Repair
• Hip Cartilage Repair
• Ankle & Foot Cartilage Repair
• Shoulder Cartilage Repair
• Other

By End User

• Hospitals & Orthopedic Clinics
• Academic & Research Institutes
• Others

By Region

• North America (By Treatment, Material, Application, End User, and Country)
  • U.S.
• By Treatment
  • Canada
• By Treatment
• Europe (By Treatment, Material, Application, End User, and Country/Sub-region)
  • Germany
• By Treatment
  • U.K.
• By Treatment
  • France
• By Treatment
  • Spain
• By Treatment
  • Italy
• By Treatment
  • Scandinavia
• By Treatment
  • Rest of Europe
• By Treatment
• Asia Pacific (By Treatment, Material, Application, End User, and Country/Sub-region)
  • China
• By Treatment
  • Japan
• By Treatment
  • India
• By Treatment
  • Australia
• By Treatment
  • Southeast Asia
• By Treatment
  • Rest of Asia Pacific
• By Treatment
• Latin America (By Treatment, Material, Application, End User, and Country/Sub-region)
  • Brazil
• By Treatment
  • Mexico
• By Treatment
  • Rest of Latin America
• By Treatment
• Middle East and Africa (By Treatment, Material, Application, End User, and Country/Sub-region)
  • GCC
• By Treatment
  • South Africa
• By Treatment
  • Rest of Middle East and Africa
• By Treatment

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2023/2024
• 4.2. Technological Advancements in Cartilage Repair
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Treatment
  • 5.1.1. Cell-based Approaches
    • 5.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 5.1.1.2. Stem Cell-based Therapy
    • 5.1.1.3. Others
  • 5.1.2. Non-cell-based Approaches
    • 5.1.2.1. Osteochondral Allograft Transplantation
    • 5.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 5.1.2.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Material
  • 5.2.1. Collagen-based Materials
  • 5.2.2. Hyaluronic Acid-based Materials
  • 5.2.3. Hydrogels
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Knee Cartilage Repair
  • 5.3.2. Hip Cartilage Repair
  • 5.3.3. Ankle & Foot Cartilage Repair
  • 5.3.4. Shoulder Cartilage Repair
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals & Orthopedic Clinics
  • 5.4.2. Academic & Research Institutes
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East and Africa

6. North America Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Treatment
  • 6.1.1. Cell-based Approaches
    • 6.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 6.1.1.2. Stem Cell-based Therapy
    • 6.1.1.3. Others
  • 6.1.2. Non-cell-based Approaches
    • 6.1.2.1. Osteochondral Allograft Transplantation
    • 6.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 6.1.2.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Material
  • 6.2.1. Collagen-based Materials
  • 6.2.2. Hyaluronic Acid-based Materials
  • 6.2.3. Hydrogels
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Knee Cartilage Repair
  • 6.3.2. Hip Cartilage Repair
  • 6.3.3. Ankle & Foot Cartilage Repair
  • 6.3.4. Shoulder Cartilage Repair
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals & Orthopedic Clinics
  • 6.4.2. Academic & Research Institutes
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Method
  • 6.5.2. Canada
    • 6.5.2.1. By Method

7. Europe Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Treatment
  • 7.1.1. Cell-based Approaches
    • 7.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 7.1.1.2. Stem Cell-based Therapy
    • 7.1.1.3. Others
  • 7.1.2. Non-cell-based Approaches
    • 7.1.2.1. Osteochondral Allograft Transplantation
    • 7.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 7.1.2.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Material
  • 7.2.1. Collagen-based Materials
  • 7.2.2. Hyaluronic Acid-based Materials
  • 7.2.3. Hydrogels
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Knee Cartilage Repair
  • 7.3.2. Hip Cartilage Repair
  • 7.3.3. Ankle & Foot Cartilage Repair
  • 7.3.4. Shoulder Cartilage Repair
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals & Orthopedic Clinics
  • 7.4.2. Academic & Research Institutes
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Method
  • 7.5.2. Germany
    • 7.5.2.1. By Method
  • 7.5.3. France
    • 7.5.3.1. By Method
  • 7.5.4. Spain
    • 7.5.4.1. By Method
  • 7.5.5. Italy
    • 7.5.5.1. By Method
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Method
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Method

8. Asia Pacific Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Treatment
  • 8.1.1. Cell-based Approaches
    • 8.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 8.1.1.2. Stem Cell-based Therapy
    • 8.1.1.3. Others
  • 8.1.2. Non-cell-based Approaches
    • 8.1.2.1. Osteochondral Allograft Transplantation
    • 8.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 8.1.2.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Material
  • 8.2.1. Collagen-based Materials
  • 8.2.2. Hyaluronic Acid-based Materials
  • 8.2.3. Hydrogels
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Knee Cartilage Repair
  • 8.3.2. Hip Cartilage Repair
  • 8.3.3. Ankle & Foot Cartilage Repair
  • 8.3.4. Shoulder Cartilage Repair
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals & Orthopedic Clinics
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Method
  • 8.5.2. Australia
    • 8.5.2.1. By Method
  • 8.5.3. China
    • 8.5.3.1. By Method
  • 8.5.4. India
    • 8.5.4.1. By Method
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Method
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Method

9. Latin America Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Treatment
  • 9.1.1. Cell-based Approaches
    • 9.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 9.1.1.2. Stem Cell-based Therapy
    • 9.1.1.3. Others
  • 9.1.2. Non-cell-based Approaches
    • 9.1.2.1. Osteochondral Allograft Transplantation
    • 9.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 9.1.2.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Material
  • 9.2.1. Collagen-based Materials
  • 9.2.2. Hyaluronic Acid-based Materials
  • 9.2.3. Hydrogels
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Knee Cartilage Repair
  • 9.3.2. Hip Cartilage Repair
  • 9.3.3. Ankle & Foot Cartilage Repair
  • 9.3.4. Shoulder Cartilage Repair
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals & Orthopedic Clinics
  • 9.4.2. Academic & Research Institutes
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Method
  • 9.5.2. Mexico
    • 9.5.2.1. By Method
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Method

10. Middle East and Africa Cartilage Repair Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Treatment
  • 10.1.1. Cell-based Approaches
    • 10.1.1.1. Autologous Chondrocyte Implantation (ACI)
    • 10.1.1.2. Stem Cell-based Therapy
    • 10.1.1.3. Others
  • 10.1.2. Non-cell-based Approaches
    • 10.1.2.1. Osteochondral Allograft Transplantation
    • 10.1.2.2. Osteochondral Autograft Transplantation (OAT) / Mosaicplasty
    • 10.1.2.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Material
  • 10.2.1. Collagen-based Materials
  • 10.2.2. Hyaluronic Acid-based Materials
  • 10.2.3. Hydrogels
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Knee Cartilage Repair
  • 10.3.2. Hip Cartilage Repair
  • 10.3.3. Ankle & Foot Cartilage Repair
  • 10.3.4. Shoulder Cartilage Repair
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals & Orthopedic Clinics
  • 10.4.2. Academic & Research Institutes
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Method
  • 10.5.2. GCC
    • 10.5.2.1. By Method
  • 10.5.3. Rest of Middle East and Africa
    • 10.5.3.1. By Method

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Vericel Corporation
  • 11.2.2. Zimmer Biomet Holdings, Inc.
  • 11.2.3. Stryker Corporation
  • 11.2.4. Arthrex, Inc.
  • 11.2.5. Smith & Nephew plc
  • 11.2.6. Johnson & Johnson
  • 11.2.7. Anika Therapeutics, Inc.
  • 11.2.8. Geistlich Pharma AG
  • 11.2.9. MTF Biologics
  • 11.2.10. AlloSource